Interferon beta for secondary progressive multiple sclerosis: a systematic review

This systematic review of interferon treatment in secondary progressive MS (SPMS) includes five randomised placebo controlled trials of IFNβ in SPMS patients and found that although relapse rates were reduced in patients receiving treatment vs. placebo, that disability progression was not.

Authors: La Mantia L, Vacchi L, Rovaris M, Di Pietrantonj C, Ebers G, Fredrikson S, Filippini G.

Source: J Neurol Neurosurg Psychiatry. 2012 Sep 5. [Epub ahead of print]

Read the abstract


Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial